Introne Wendy J, Phornphutkul Chanika, Bernardini Isa, McLaughlin Kevin, Fitzpatrick Diana, Gahl William A
Section on Human Biochemical Genetics, Heritable Disorders Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-1851, USA.
Mol Genet Metab. 2002 Sep-Oct;77(1-2):136-42. doi: 10.1016/s1096-7192(02)00121-x.
In alkaptonuria, homogentisate 1,2-dioxygenase deficiency causes tissue accumulation of homogentisic acid (HGA), followed by signs and symptoms of ochronosis. These include massive urinary excretion of HGA, arthritis and joint destruction, pigmentation of cartilage and connective tissue, and cardiac valve deterioration. We describe a 46-year-old man with alkaptonuria and diabetic renal failure whose plasma HGA concentration was twice that of any other alkaptonuria patient, and whose ochronosis progressed much more rapidly than that of his two alkaptonuric siblings. After renal transplantation, the plasma HGA normalized, and the daily urinary excretion of HGA decreased by 2-3g. This case illustrates the critical role of renal tubular secretion in eliminating HGA from the body, and suggests that renal transplantation in a uremic patient not only restores HGA excretion, but may also provide homogentisate 1,2-dioxygenase activity for the metabolism of HGA.
在黑尿症中,尿黑酸1,2-双加氧酶缺乏导致尿黑酸(HGA)在组织中蓄积,继而出现褐黄病的体征和症状。这些包括大量HGA经尿液排泄、关节炎和关节破坏、软骨和结缔组织色素沉着以及心脏瓣膜退变。我们描述了一名患有黑尿症和糖尿病肾衰竭的46岁男性,其血浆HGA浓度是其他任何黑尿症患者的两倍,且其褐黄病进展比他的两名患黑尿症的兄弟姐妹快得多。肾移植后,血浆HGA恢复正常,HGA每日尿排泄量减少2 - 3克。该病例说明了肾小管分泌在从体内清除HGA中的关键作用,并表明尿毒症患者进行肾移植不仅可恢复HGA排泄,还可能为HGA的代谢提供尿黑酸1,2-双加氧酶活性。